Irritable Bowel Syndrome Treatment Market is Expected to Expand at a CAGR of 7.58% During Forecast 2018-2023
Market Highlights: According to Market Research Future (MRFR)’s new study, the global irritable bowel syndrome treatment market is projected to thrive at a CAGR of 7.58% during the forecast period 2018 to 2023. The valuation of the global market has been estimated to reach USD 2,988.6 Mn towards the end of 2023 from USD 1,890.9 Mn in 2017. It is presumed to scale new heights over the next few years owing to the consolidation of a substantial patient population. The constantly increasing economic burden of IBS affects work productivity and leads to an increase in healthcare costs. This, in turn, has raised awareness about the disorder, thus, favoring the expansion of the global market. In addition, the large-scale prevalence of anxiety and depression is anticipated to catalyze the growth of the irritable bowel syndrome treatment market over the assessment period. The key players are continually investing in drug development for capitalizing on the rising patient pool. Furtherm...